In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila

被引:7
作者
Edelstein, PH
Hu, BF
Edelstein, MAC
机构
[1] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/AAC.49.6.2533-2535.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
LBM415 activity against extracellular and intracellular Legionella pneumophila was studied. The LBM415 MIC,, for 20 Legionella sp. strains was 4 μ g/ml, versus 0.06, 0.25, and ≤ 0.03 μ g/ml for azithromycin, erythromycin, and levofloxacin, respectively. LBM415 (0.5 and 16 μ g/ml) reversibly prevented intracellular growth of two L. pneumophila strains and was less active than erythromycin.
引用
收藏
页码:2533 / 2535
页数:3
相关论文
共 7 条
[1]   WIN-57273 IS BACTERICIDAL FOR LEGIONELLA-PNEUMOPHILA GROWN IN ALVEOLAR MACROPHAGES [J].
EDELSTEIN, PH ;
EDELSTEIN, MAC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (12) :2132-2136
[2]   In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia [J].
Edelstein, PH ;
Edelstein, MAC ;
Lehr, KH ;
Ren, JJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) :117-126
[3]   Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L-pneumophila pneumonia [J].
Edelstein, PH ;
Weiss, WJ ;
Edelstein, MAC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :533-540
[4]   COMPARISON OF 3 BUFFERS USED IN THE FORMULATION OF BUFFERED CHARCOAL-YEAST EXTRACT MEDIUM [J].
EDELSTEIN, PH ;
EDELSTEIN, MAC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (12) :3329-3330
[5]   INVITRO ACTIVITY OF AZITHROMYCIN AGAINST CLINICAL ISOLATES OF LEGIONELLA SPECIES [J].
EDELSTEIN, PH ;
EDELSTEIN, MAC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (01) :180-181
[6]   LEGIONNAIRES-DISEASE BACTERIUM (LEGIONELLA-PNEUMOPHILA) MULTIPLIES INTRACELLULARLY IN HUMAN-MONOCYTES [J].
HORWITZ, MA ;
SILVERSTEIN, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (03) :441-450
[7]   Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates [J].
Jones, RN ;
Moet, GJ ;
Sader, HS ;
Fritsche, TR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :804-807